Extasy Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-06-2024
- Paid Up Capital ₹ 0.10 M
as on 26-06-2024
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -29.89%
(FY 2020)
- Profit 317.38%
(FY 2020)
- Ebitda 87.19%
(FY 2020)
- Net Worth 24.32%
(FY 2020)
- Total Assets -9.79%
(FY 2020)
About Extasy Healthcare
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Santhosh Patake, Padubidri Bharathraj, and Nikeetha Guptha serve as directors at the Company.
- CIN/LLPIN
U24239KA2008PTC045169
- Company No.
045169
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Feb 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
What products or services does Extasy Healthcare Private Limited offer?
Extasy Healthcare Private Limited offers a wide range of products and services, including Calcium Tablet, Calcium & Vitamin D3 Tablet, Organic Soap, Goat Milk Soap, Fashion & Leather Belts, Belts, Orthopedic Equipment & Supplies, Lower Body Orthotic Device, Body Cream, Moisturizing Cream.
Who are the key members and board of directors at Extasy Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santhosh Patake  | Director | 05-Feb-2008 | Current |
| Padubidri Bharathraj | Director | 05-Feb-2008 | Current |
| Nikeetha Guptha | Director | 15-Dec-2017 | Current |
Financial Performance of Extasy Healthcare.
Extasy Healthcare Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 29.89% decrease. The company also saw a substantial improvement in profitability, with a 317.38% increase in profit. The company's net worth Soared by an impressive increase of 24.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Extasy Healthcare?
In 2020, Extasy Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Extasy Healthcare?
Unlock and access historical data on people associated with Extasy Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Extasy Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Extasy Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
